Based on the IQVIA Holdings Inc stock forecast from 14 analysts, the average analyst target price for IQVIA Holdings Inc is USD 264.95 over the next 12 months. IQVIA Holdings Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of IQVIA Holdings Inc is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, IQVIA Holdings Inc’s stock price was USD 197.60. IQVIA Holdings Inc’s stock price has changed by -2.63% over the past week, -14.53% over the past month and -4.75% over the last year.
No recent analyst target price found for IQVIA Holdings Inc
No recent average analyst rating found for IQVIA Holdings Inc
Company Overview IQVIA Holdings Inc
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina. Read Less
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Rese...Read More
Frequently Asked Questions About IQVIA Holdings Inc (IQV) Stock
Based on ratings from 14 analysts IQVIA Holdings Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 18 buy, sell and 4 hold ratings.
Unfortunately we do not have enough data on IQV's stock to indicate if its a good dividend stock.
Based on targets from 14 analysts, the average taret price for IQV is USD 264.95 over the next 12 months. The maximum analyst target price is USD 300 while the minimum anlayst target price is USD 230.
IQV stock's Price/Earning ratio is 27.48.
Our analysis grades IQV stock's Price / Earning ratio at D. This means that IQV stock's Price/Earning ratio is above 37% of the stocks in the Diagnostics & Research sector in the NYE exchange.
Based on this IQV may be fairly valued for its sector
The last closing price of IQV's stock was USD 197.60.
The most recent market capitalization for IQV is USD 37.96B.
Based on targets from 14 analysts, the average taret price for IQV is projected at USD 264.95 over the next 12 months.
This means that IQV's stock price may go up by +34.09% over the next 12 months.
We can't find any ETFs which contains IQVIA Holdings Inc's stock.
As per our most recent records IQVIA Holdings Inc has 88,000 Employees.
IQVIA Holdings Inc's registered address is 2400 Ellis Road, Durham, NC, United States, 27703.
You can get more information about it from IQVIA Holdings Inc's website at https://www.iqvia.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About IQVIA Holdings Inc (IQV) Stock
Based on ratings from 14 analysts IQVIA Holdings Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 18 buy, sell and 4 hold ratings.
Unfortunately we do not have enough data on IQV's stock to indicate if its a good dividend stock.
Based on targets from 14 analysts, the average taret price for IQV is USD 264.95 over the next 12 months. The maximum analyst target price is USD 300 while the minimum anlayst target price is USD 230.
IQV stock's Price/Earning ratio is 27.48.
Our analysis grades IQV stock's Price / Earning ratio at D. This means that IQV stock's Price/Earning ratio is above 37% of the stocks in the Diagnostics & Research sector in the NYE exchange.
Based on this IQV may be fairly valued for its sector
The last closing price of IQV's stock was USD 197.60.
The most recent market capitalization for IQV is USD 37.96B.
Based on targets from 14 analysts, the average taret price for IQV is projected at USD 264.95 over the next 12 months.
This means that IQV's stock price may go up by +34.09% over the next 12 months.
We can't find any ETFs which contains IQVIA Holdings Inc's stock.
As per our most recent records IQVIA Holdings Inc has 88,000 Employees.
IQVIA Holdings Inc's registered address is 2400 Ellis Road, Durham, NC, United States, 27703.
You can get more information about it from IQVIA Holdings Inc's website at https://www.iqvia.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IQV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
